Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Inflammatory Bowel Disease
94%
Crohn's Disease
80%
Ulcerative Colitis
52%
Diseases
49%
Patient with Inflammatory Bowel Disease
42%
Patient with Crohn's Disease
34%
Prevalence
31%
Stress Fracture
30%
Adolescence
19%
Clinical Trial
19%
Adverse Event
19%
Placebo
18%
Infliximab
18%
Quality of Life
17%
Body Mass Index
16%
Odds Ratio
16%
Iron Deficiency
15%
Fistula
15%
Colon
15%
Oral
15%
Pediatrics
14%
Patient Referral
14%
Health Care Cost
13%
Maturity Onset Diabetes of the Young
13%
Colectomy
13%
Biological Product
13%
Retrospective Cohort Study
12%
Emergency Department
12%
Computer Assisted Tomography
12%
Endoscopic Ultrasound
12%
Coeliac Disease
12%
Infusion
12%
Diabetes Mellitus
12%
Systemic Disease
12%
Oral Drug Administration
11%
Randomized Controlled Trial
11%
Hypertension
11%
Steroids
11%
Patient with Ulcerative Colitis
10%
Stricture
10%
Isotopes of Calcium
9%
Blood Pressure
8%
Colitis
8%
Triacylglycerol
8%
Retrospective Study
8%
Anemia
8%
Nutrition
8%
Diagnostic Test
8%
Diabetes
8%
Real-World Data
7%
Keyphrases
Crohn's Disease
100%
Inflammatory Bowel Disease
85%
Ulcerative Colitis
46%
Israeli
25%
Israel
25%
Oral Administration
25%
Infliximab
25%
Extracted Protein
25%
Young Men
22%
Colon
21%
Active Ulcerative Colitis
18%
Phase I Trial
18%
Odds Ratio
15%
Clinical Remission
15%
Randomized Placebo-controlled Trial
15%
Retrospective Cohort Study
14%
Triglyceride Level
13%
Military Recruits
13%
Systemic Disease
13%
Gastrointestinal Diseases
13%
Hospitalization
13%
Immune Regulation
12%
Emergency Department
12%
Placental Histopathological Lesions
12%
Abdominal
12%
Population-based Study
12%
Fistula
12%
Pre-diabetes (pre-DM)
12%
Oral Immune Therapy
12%
Diabetes in Young
12%
Epi-IIRN
12%
Perianal Fistulising Crohn's Disease
12%
Adverse Neonatal Outcomes
12%
Disability
11%
Human Pluripotent Stem Cells (hPSCs)
11%
Remission
11%
Clinical Response
11%
Cytomegalovirus
11%
Adverse Events
10%
Body Mass Index
10%
95% Confidence Interval
9%
Well Tolerated
9%
Colitis
9%
Iron Deficiency
9%
Placebo Groups
9%
Multicenter Retrospective Study
8%
Loss of Response
8%
Clinical Characteristics
8%
Surgery Rates
8%
Chronic Hepatitis C Virus Infection
8%